| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.072 | 16.282 | 11.785 | 169 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.500 | 16.709 | 11.810 | 171 | 9 | 513 | 10 | 0 | 0 | 0 |
| Total Expenses - EUR | 24.758 | 32.656 | 10.378 | 6.008 | 1.192 | 1.386 | -371 | 1.554 | 251 | 64 |
| Gross Profit/Loss - EUR | -21.258 | -15.947 | 1.432 | -5.837 | -1.183 | -873 | 381 | -1.554 | -251 | -64 |
| Net Profit/Loss - EUR | -21.350 | -16.280 | 1.314 | -5.842 | -1.183 | -887 | 363 | -1.554 | -251 | -64 |
| Employees | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Laboratorul Analitic Pharmaquest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.643 | 613 | 23 | 12 | 2 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 24.251 | 19.169 | 17.581 | 12.203 | 10.604 | 10.163 | 9.397 | 4.045 | 4.305 | 4.237 |
| Inventories | 1.368 | 618 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.637 | 14.902 | 12.546 | 9.091 | 8.918 | 8.760 | 8.496 | 4.045 | 4.039 | 4.016 |
| Cash | 10.245 | 3.649 | 5.035 | 3.112 | 1.684 | 1.402 | 901 | 0 | 266 | 221 |
| Shareholders Funds | 10.965 | -5.428 | -4.022 | -9.790 | -10.822 | -11.503 | -10.885 | -12.473 | -12.686 | -12.679 |
| Social Capital | 135 | 134 | 131 | 129 | 126 | 124 | 121 | 122 | 121 | 121 |
| Debts | 16.464 | 25.503 | 21.683 | 22.024 | 21.428 | 21.666 | 20.282 | 16.518 | 16.991 | 16.917 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Laboratorul Analitic Pharmaquest Srl